Discontinuation report SUPREFACT
| Report ID | 151039 |
| Drug Identification Number | 02225158 |
| Brand name | SUPREFACT |
| Common or Proper name | Buserelin |
| Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | BUSERELIN |
| Strength(s) | 100MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | NASAL NASAL |
| Packaging size | 10ml Spray |
| ATC code | L02AE |
| ATC description | HORMONES AND RELATED AGENTS |
| Reason for discontinuation | Manufacturing issues |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2021-05-31 |
| Remaining supply date | 2021-05-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2021-12-13 | French | Compare |
| v1 | 2021-12-13 | English | Compare |
Showing 1 to 2 of 2